Next Generation of FGF-21 Analogs: Engineered Short-and Long-Acting FGF-21 Variants with Improved In Vivo Potency, Stability, and Biopharmaceutical Properties-MedSci.cn

Next Generation of FGF-21 Analogs: Engineered Short-and Long-Acting FGF-21 Variants with Improved In Vivo Potency, Stability, and Biopharmaceutical Properties

Gonciarz, M; Driver, D; Dickinson, CD; Ford, A; Morehead, TA; Dunbar, JD; Baker, HE; O'Farrell, LS; Murphy, AT; Hansen, RJ; Adams, AC; Coskun, T; Darling, R

DIABETES, 2017; 66 ( ): A530

科室
- - 订阅+
  - 更多科室
工具
服务